New Phase 4 OSCAR Trial Data Showed that Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Decreased Acne Lesions Therefore Reducing the Risk of Scars in Moderate-to-Severe Acne Patients Press release
Galderma Announces Results of ALAMO: A Real-World, Phase 4 Study Demonstrating Efficacy and Safety of Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Plus Oral Doxycycline 200 mg in Treating Severe Inflammatory Acne Press release
Nestlé Skin Health Announces the FDA Approval of Restylane® Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands Press release
World-Renowned Celebrity and Fashion Manicurist Deborah Lippmann Joins Forces with Galderma on “Face Your Hands” Campaign to Help Women Achieve Younger-Looking Hands with Restylane® Lyft Press release
Galderma Initiates Six New Studies, Increasing Company’s Commitment to Aesthetic Research and Innovation Press release
Galderma Partners with National Breast Cancer Foundation for 4th Annual Pink Day Event to Increase Breast Cancer Awareness Press release
Fort Worth’s Galderma, Maker of Cetaphil, Presents the 4th Annual Wonder Run 5K and 1K Kids Waddle to Benefit Children’s Skin Disease Foundation Press release